Merck & Co., Drugmaker | featured news

Merck ponders next step for troubled heart drug

Officials at drugmaker Merck & Co. say they will take more time to decide what to do about an experimental blood thinner that gave disappointing results in a second big study....

 

Merck to pay nearly $1 billion to settle U.S. charges

Merck to pay nearly $1 billion to settle U.S. charges

Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

 

Merck to buy Schering-Plough in $41.1 billion deal

Merck to buy Schering-Plough in $41.1 billion deal

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

 

Subscribe to this RSS topic: Syndicate content